baber/WOPTO huggingface dataset:
Patent NZ-565225-A (NZ)
Title: Mop head and mop
Inventor: HOWLEY ANDREW
Filed: 2008-01-22
Abstract: A mop head is disclosed comprising: a pair of wings pivotable between a mopping orientation wherein the wings lie in a common substantially horizontal plane, and a squeezing orientation, wherein said wings lie outside of said horizontal plane; one or more projections extending out of the plane of each wing; and an actuator having a first side which contacts the wings when the mop head is in the mopping orientation and an opposed second side, the projections being configured such that a portion thereof is moved into a return position at which the projection contacts the second side of the actuator as the mop head is moved from the mopping orientation into the squeezing orientation, the actuator being operable to move the projections when in the return position so as to return the mop head to the mopping orientation.
Patent NZ-565681-A (NZ)
Title: Photonic crystal biosensor structure and fabrication method
Inventor: CUNNINGHAM BRIAN T
IPC: G01N33/52
Filed: 2006-06-29
Abstract: A sensor comprises a nanoporous material supported on a substrate and coated on a top surface with a high dielectric constant dielectric coating. The coating and the nanoporous material form a sub-wavelength period grating structure.
Patent NZ-583389-A (NZ)
Title: Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
Inventor: XIA MINGDE
IPC: A61P37/02
Filed: 2008-08-12
Abstract: Disclosed is a pyrazole compound of formula (I) where the substituents are as disclosed is the specification. Examples of the compounds are: 5-[2-(4-chloro-phenyl)-1-methyl-vinyl]-1-(2,4-dichloro-phenyl)-4-methyl-1H-pyrazole-3-carboxylic acid [(1S)-1-cyclohexyl-ethyl]-amide, 5-[2-(4-chloro-phenyl)-1-methyl-vinyl]-1-(2,4-dichloro-phenyl)-4-methyl-1H-pyrazole-3-carboxylic acid [(1S)-1-phenyl-ethyl]-amide, 5-[2-(4-chloro-phenyl)-1-methyl-vinyl]-1-(2,4-dichloro-phenyl)-4-methyl-1H-pyrazole-3-carboxylic acid [(1R,2S,4R)-1,3,3-trimethylbicyclo[2.2.1 ]hept-2-yl]-amide. Also disclosed is a pharmaceutical composition comprising a compound of formula (I), a process for making the composition and the use of a compound in the manufacture of a medicament for treating a cannabinoid receptor mediated syndrome such as disorder or disease is related to appetite, metabolism, diabetes, glaucoma-associated intraocular pressure, social and mood disorders, seizures, substance abuse, learning, cognition or memory, organ contraction or muscle spasm, bowel disorders, respiratory disorders, locomotor activity or movement disorders, immune and inflammation disorders, unregulated cell growth, pain management or neuroprotection. The medicament may also comprise an anticonvulsant or a contraceptive agent such as topiramate, analogs of topiramate, carbamazepine, valproic acid, lamotrigine, gabapentin, phenytoin, progestin-only contraceptive, a contraceptive having a progestin component and an estrogen component, or an oral contraceptive optionally having a folic acid component.
Patent NZ-588166-A (NZ)
Title: Solar energy collector situated under a mortar based cover layer
Inventor: NYS MANU
IPC: F24S10/75
Filed: 2009-02-26
Abstract: Disclosed is a device or panel for collecting and utilizing solar heat or thermal energy generated by the sun, using a layered construction with a thermally insulating substrate layer and a cover layer of a curable cement or mortar. On the substrate layer a continuous flexible plastic tube circuit system of at least two tubes joined together arranged in a grid pattern through which a fluid or liquid can flow or be pumped or otherwise transported in order to regulate the temperature in the tube system, this tube system being partially or completely embedded in the mortar laying flush with the outwardly facing surface of the cover layer, wherein the mortar of the cover layer comprises insulating granules, cement, water and additives.
Patent NZ-588839-A (NZ)
Title: Multivalent vla-4 antagonists comprising polyethylene glycol moieties
Inventor: KONRADI ANDREI W
IPC: A61K47/48
Filed: 2005-07-08
Abstract: Provided are VLA-4 antagonists, with an exemplary structure (iia) as depicted. The compounds are conjugates of a bio-compatible polymer moiety and a branched-arm hub molecule and can comprise multiple polyethylene glycol moieties. The conjugate compounds can be alpha4beta1 or alpha4beta7 inhibitors and can be used to treat inflammation and autoimmune diseases.
Patent NZ-589640-A (NZ)
Title: Method and device for the detection of microsleep events
Inventor: FARBOS BRUNO
IPC: A61B3/10
Filed: 2009-05-27
Abstract: 589640 A method of detecting a microsleep event in a person (10) is disclosed. It is particularly useful for drivers of vehicles. The method includes determining a number of eye openness factors by measuring a number of distances between an upper eyelid and a lower eyelid of at least one eye over a time period using a camera (102) and processor (106). Graphical representations of the eye openness factors are then generated. Changes in the eye openness factors over the time period are correlated with a reference eye closure pattern indicative of the microsleep event. If such an event is determined to have occurred an alert make the person aware. Also disclosed is a microsleep event detection device (100).
Patent NZ-590995-A (NZ)
Title: Oral formulations of salts of isophosphoramide mustard and its analogs and their use in the treatment of a condition characterised by abnormal cell growth or differentiation (such as cancer)
Inventor: WALIGORA FRANK WALTER
IPC: A61K31/675
Filed: 2009-07-30
Abstract: Disclosed are oral formulations of the isophosphoramide mustard derivatives of Formula (E), additionally comprising lubricant, diluent and disintegrant. Also disclosed is the use of the oral formulation of isophosphoramide mustard derivatives of Formula (E) for treating a condition characterised by abnormal cell growth or differentiation (such as cancer).
Patent NZ-591407-A (NZ)
Title: Electrical machine with dual insulated coil assembly
Inventor: SIRELI EYUP METE
IPC: H01F27/23
Filed: 2009-07-09
Abstract: 591407 Disclosed is an electrical machine (500) configured for flooded operation in an electrically conductive medium. The machine (500) has at least one coil assembly (502) that has at least one magnetic core element with at least one first dielectric insulation layer (526) surrounding the core element. The core element also has at least one waterproof adhesive layer surrounds the first dielectric insulation layer (526) and at least one electrical winding around the magnetic core element. The electrical winding is comprised of at least one continuous length of flexible electrical cable (522) which has a central conducting element and at least one second dielectric insulation layer surrounding the central conducting element. The second dielectric insulation layer has at least one waterproof molecular barrier material. At least one waterproof adhesive layer is applied to the flexible electrical cable (522) such as to substantially surround the flexible electrical cable in the electrical winding (522).
Patent NZ-591807-A (NZ)
Title: Display and controls for a cpap device
Inventor: VIRR ALEXANDER
IPC: A61M16/00
Filed: 2009-09-17
Abstract: A control interface for a device is disclosed. The control interface has a display (302) for displaying a device control menu; a rotary control dial (306) for operation by a user to navigate within the control menu; and a menu control which causes entry to a menu list of the control menu to occur at a predetermined position in the menu list, determines at least one user parameter from operation of the control dial by the user in navigation of the menu, and applies the determined user parameter to subsequent operation of the control dial within that menu. Further disclosed is the apparatus for treating sleep disordered breathing comprising a flow generator for delivering a supply of breathable gas at positive pressure to a patient; and the above described control interface.
Patent NZ-594879-A (NZ)
Title: Discrimination of cheyne -stokes breathing patterns by use of oximetry signals
Inventor: LAU CHUN YUI
IPC: A61B5/087
Filed: 2010-04-15
Abstract: A computer implemented method and apparatus for detecting the occurrence of Cheyne-Stokes breathing are disclosed. An apparatus comprises a memory for blood gas data representing a measured blood gas signal and a processor coupled with the memory. The processor is configured (a) to determine a duration of one or more contiguous periods of changing saturation of a blood gas from the blood gas data and (b) to detect an occurrence of Cheyne-Stokes respiration from a comparison of the determined duration and a threshold derived to differentiate saturation changes due to Cheyne-Stokes respiration and saturation changes due to obstructive sleep apnea.
Patent NZ-596179-A (NZ)
Title: Apparatus and method for replacing a diseased cardiac valve
Inventor: NAVIA JOSE LUIS
IPC: A61B17/00
Filed: 2010-04-28
Abstract: An apparatus (10a) for treating heart disease, and more particularly to self-expandable apparatus and methods for treating a diseased native cardiac valve. The native cardiac valve has at least one leaflet and is surrounded by a native cardiac valve annulus, the native cardiac valve annulus having a superior aspect and an inferior aspect. The apparatus (10a) has an expandable support member (56) being movable from a radially collapsed configuration to a radially expanded configuration, and having a first end portion, a second end portion and a main body portion extending between the first and second end portions. A prosthetic cardiac valve is operably secured within the main body portion of the expandable support member (56). A securing member (84) is operably connected to the expandable support member (56) the securing member (84) comprising an elongated body member (86) having a first end (88), a second end (90), and a main body portion (92) integrally formed with and extending between the first and second ends (88, 90). The second end (90) includes a first attachment member (96) operably connected thereto for contacting the inferior aspect of the native cardiac valve annulus when the expandable support member (56) is in an expanded configuration.
Patent NZ-600106-A (NZ)
Title: Plant wall and modules for growing plants
Inventor: LAURENCE MARK
IPC: A01G9/02
Filed: 2010-11-08
Abstract: A plant wall (2) for growing plants comprising. The wall has module (10) for housing an inert growing medium, the module (10) having a front (12), back, top (18), and a bottom (14). The inert growing medium is configured to receive at least one plant. The wall has a support frame (6) for securing the module (10) to a wall (4); an irrigation system for delivering water and nutrients to the growing medium; and a drainage channel formed between the back of the module and the support frame, the drainage channel formed in a drainage membrane. Excess water delivered to the inert growing medium by the irrigation system exits from the growing medium through the drainage membrane and into the drainage channel without entering into another module (10) located below.
Patent NZ-601127-A (NZ)
Title: Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
Inventor: VELA HERNANDEZ JOSE MIGUEL
IPC: A61K31/00
Filed: 2011-02-04
Abstract: 601127 The disclosure refers to a combination comprising a sigma ligand of formula (I) and an opioid or opiate for use in the prevention and/or treatment of pain developed as a consequence of surgery, especially peripheral neuropathic pain, allodynia, causalgia, hyperalgesia, hyperesthesia, hyperpathia, neuralgia, neuritis or neuropathy. The invention also refers to the sigma ligands of formula (I) for use in potentiating the analgesic effect of an opioid or opiate selected from morphine or a structural derivative thereof, tramadol, sufentanil, remifentanil, fentanyl, tapentadol, oxycodone, and buprenorphine, and/or for decreasing the dependency induced thereby when said opioid or opiate is used in the prevention and/or treatment of pain developed as a consequence of surgery. Sigma ligands of the disclosure include: 1-[2-(1-(4-Methoxyphenyl)-5-methyl-1H-pyrazol-3-yloxy)ethyl]piperidine, 2-{ 2-[1-(3 ,4-dichlorophenyl)-5-phenyl-1H-pyrazol-3-yloxy]ethyl} -1,2,3,4-tetrahydroisoquinoline, 1-(3,4-Dichlorophenyl)-5-isopropyl-3-[2-(pyrrolidin-1-yl)ethoxy]-1H-pyrazole, 1-{ 4-[1-(3,4-Dichlorophenyl)-1H-pyrazol-3-yloxy]butyl} piperidine and 5-Methyl-1-(naphthalen-2-yl)-3-[2-(pyrrolidin-1-yl)ethoxy]-1H-pyrazole
Patent NZ-602606-A (NZ)
Title: Enhanced gravity separation device using closely spaced channels
Inventor: GALVIN KEVIN PATRICK
IPC: B04B5/02
Filed: 2011-03-29
Abstract: 602606 Disclosed is a gravity separation device for fluid feed comprising denser and less dense matter. The device comprises one or more vessels (2); a central shaft (1) and means for introducing feed. The vessels (2) comprise outer (6) and inner (7) regions which rotate about a central shaft (1). The feed is introduced into the vessels (2) and is directed to the outer regions (6). An array of closely spaced inclined plates (8) are positioned within each vessel (2) between the outer (6) and inner (7) regions. Overflow of less dense matter reports to the inner region (7). Underflow of denser matter reports to the outer region (6).
Patent NZ-609712-A (NZ)
Title: Biomarkers for predicting the efficacy of an immunotherapy against cancer
Inventor: WEINSCHENK TONI
IPC: G01N33/574
Filed: 2011-11-22
Abstract: Disclosed is a method for predicting a beneficial effect of an immunotherapy in a cancer patient, comprising determining the level of at least one marker selected from the group consisting of Apolipoprotein A1 (ApoA1) in a sample previously obtained from said cancer patient, - wherein a level of said marker at least 10 % higher as compared to a median level of said marker in a given cancer patient population is indicative of a beneficial effect of an immunotherapy for said cancer patient, - wherein said cancer patient is experiencing a cancer selected from the group consisting of renal cell carcinoma (RCC), colourectal cancer (CRC), gastric cancer (GC), melanoma, nonsmall- cell lung cancer (NSCLC), glioblastoma, and adenocarcinomas of any type; - wherein said sample is selected from the group consisting of whole blood, peripheral blood, or fractions thereof, serum, buffy coat, tumour tissue, lymphatic fluid, urine, bone marrow, EDTA plasma, heparinised plasma, citrate plasma, heparinised whole blood, and frozen samples thereof, including frozen heparinised whole blood; - wherein said determining comprises at least one method selected from the group consisting of immunoassays, bead-based immunoassays, multiplex immunoassays, ELISA, microarray based assays, epigenetic assays, expression analysis, FACS analysis, established methods of hematology, proteomics, and mass spectrometry; - wherein said immunotherapy comprises vaccination with an anti-cancer vaccine, wherein said vaccination is at least one vaccine comprising at least one immunogenic peptide selected from the group consisting the peptides disclosed in the specification; and - wherein said beneficial effect is selected from the group consisting of longer overall survival, occurrence of single and/or multiple T-cell responses induced by the immunotherapy, retardation of tumour growth, tumour shrinkage, and longer progression free survival.
Patent NZ-611840-A (NZ)
Title: Anti-il-12/il-23 antibodies and uses thereof
Inventor: BORHANI DAVID W
IPC: C07K16/24
Filed: 2012-01-06
Abstract: Disclosed is an isolated human antibody, or antigen-binding portion thereof, that binds to the p40 subunit of IL-12 and/or IL-23, wherein the antibody, or antigen-binding portion thereof, binds to amino acid residues 15, 17-21, 23 and 58-60 of SEQ ID NO:3 (p40), or within 1-10Å of the amino acid residues; wherein the sequence is as disclosed in the specification. Also disclosed is the use of the antibody, or antigen-binding portion thereof in the preparation of a medicament for treating a subject suffering from a disorder in which the activity of IL-12 and/or IL-23 is detrimental.
Patent NZ-614621-A (NZ)
Title: Electrically controlled mortice lock assembly
Inventor: NEWMAN DONALD JOHN
IPC: E05B63/10
Filed: 2012-03-15
Abstract: A mortice lock assembly (1) including a lock means having a powered actuator that is operable in a failsafe condition or a failsecure condition. The assembly also includes a selector (12) for adjusting the condition of the lock means whereby the selector includes a rotatable member (11) that is rotatable through no more than 360° to adjust the condition of the selector.
Patent NZ-616264-A (NZ)
Title: Improvements in and relating to medicinal compositions for analgesia comprising buprenorphine and naltrexone
Inventor: CHAPLEO CHRISTOPHER BOURNE
IPC: A61P25/04
Filed: 2008-02-15
Abstract: Disclosed herein is an analgesic composition, in parenteral unit dosage form or in a unit dosage form suitable for delivery via the dermis or mucosa, comprises buprenorphine and an amount of naltrexone such that the ratio by weight of buprenorphine to naltrexone delivered to or reaching the plasma of a patient is in the range 100:1 to 5000:1. The analgesic action of the buprenorphine is potentiated by the low dose of naltrexone. Also provided are a method of treatment of pain and the use of buprenorphine and naltrexone for the manufacture of a medicament.
Patent NZ-620302-A (NZ)
Title: A grinding tool for machining brittle materials and a method of making a grinding tool
Inventor: THOLIN MICHAEL
IPC: B24D3/34
Filed: 2012-07-18
Abstract: The specification relates to a grinding tool 1 for machining brittle materials. The grinding tool 1 has a core 2 and an abrasive rim 4. The abrasive rim 4 comprises abrasive particles 5 embedded in a matrix 6. The matrix 6 comprises a sintered bronze alloy. The alloy comprises 50 to 100% of the volume of the matrix. 0.02% -5.0 % by volume of the alloy is silicon nitride in the shape of grains having an average grain size which is between 1 μm and 10μm. The invention also relates to a method of manufacturing the grinding tool. In the method, abrasive particles are mixed with metal powder and silicon nitride and the mixture is sintered.
Patent NZ-628041-A (NZ)
Title: Electroluminescent devices and their manufacture
Inventor: ZSINKO ANDREW
IPC: H05B33/10
Filed: 2013-01-03
Abstract: A process for producing a conformal electroluminescent system is disclosed. An electrically conductive base backplane film layer (16) is applied upon a substrate (12). A dielectric film layer (18) is applied upon the backplane film layer (16), and then a phosphor film layer (20) is applied upon the dielectric film layer (18). The phosphor film layer is excited by an ultraviolet radiation source during application and the ultraviolet radiation source provides visual cues while the phosphor film layer is being applied. The application of the phosphor film layer is adjusted in response to the visual cues during the phosphor application step to apply a generally uniform distribution of the phosphor material upon the dielectric film layer. An electrode film layer (22) is applied upon the phosphor film layer (20) using a substantially transparent, electrically conductive material. An electrically conductive bus bar (24) can optionally be applied upon the electrode film layer (22). The backplane film layer (16), dielectric film layer (18), phosphor film layer (20) and electrode film layer (22) are aqueous-based and are applied by spray conformal coating. The phosphor film layer is excitable by an electrical field established across the phosphor film layer upon application of an electrical charge between the backplane film layer and the electrode film layer such that the phosphor film layer emits electroluminescent light.
Patent NZ-702125-A (NZ)
Title: Armoured cable for transporting alternate current with reduced armour loss
Inventor: MAIOLI PAOLO
IPC: H01B7/26
Filed: 2012-11-13
Abstract: An armoured cable for transporting an alternate current I at a maximum allowable working conductor temperature T comprising: • - at least two cores (12) stranded together according to a core stranding lay and a core stranding pitch A; • - an armour (16) surrounding the at least two cores, said armour comprising one layer of a plurality of metal wires (16a) wound around the cores according to a helical armour winding lay and an armour winding pitch B; • - the helical armour winding lay has the same direction as the core stranding lay, • - the armour winding pitch B is of from 0.4A to 2.5A and differs from the core stranding pitch A by at least 10%.
Patent NZ-711002-A (NZ)
Title: New octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors
Inventor: HUNZIKER DANIEL
IPC: C07D487/04
Filed: 2014-03-11
Abstract: The invention provides novel compounds as autotaxin inhibitors having the general formula (I) wherein R1, Y, A, W, R2, m, n, p and q are as described herein, compositions including the compounds and methods of using the compounds.
Patent NZ-717930-A (NZ)
Title: Compositions for the treatment of hypertension and/or fibrosis
Inventor: DUGGAN KAREN ANNETTE
IPC: A61K31/416
Filed: 2014-09-17
Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
Patent NZ-719850-A (NZ)
Title: Intraocular shunt inserter
Inventor: HORVATH CHRISTOPHER
IPC: A61F9/007
Filed: 2014-11-13
Abstract: Glaucoma can be treated using intraocular shunts delivered by a shunt inserter. The present disclosure provides an inserter that allows a physician to easily actuate different components of the inserter to facilitate shunt placement. For example, the inserter can include a housing, a needle, a plunger, a slider component, and a drive component. An operator can grasp the housing to advance the needle into a patient’s eye, and the shunt can be released from the inserter by actuating the slider component, which actuates the drive component. The slider component is coupled to the housing and slidable along an elongate groove of the drive component such that movement of the slider component along the axis rotates the drive component within the housing and causes movement of the needle and the plunger.
Patent NZ-723953-A (NZ)
Title: Molluscicidal particle, bait and method of controlling harmful molluscs
Inventor: MERCIER FREDERIC
IPC: A01P9/00
Filed: 2015-02-19
Abstract: The invention relates to a molluscicidal particle formed of a solid comprising at least one compound, a so-called metallic compound, comprising at least one metal selected from the group consisting of iron, copper, zinc and aluminium, the solid being suitable for use as an ingested poison for harmful molluscs. The invention is characterized in that the solid comprises metaldehyde in a proportion which can vary towards the interior of the solid.
Patent NZ-731196-A (NZ)
Title: A novel purification process for isolation and commercial production of recombinant tnk-tpa (tenecteplase)
Inventor: RAGHUWANSHI ARJUN
IPC: C07K1/36
Filed: 2015-10-19
Abstract: The present invention relates to a process of isolating and purifying tissue plasminogen activator and its variants more specifically TNK-tPA from CHO cells, the process uses a series of affinity chromatography and filtration steps to overcome known difficulties in the industrial scale purification of TNK-tPA.
Patent NZ-732699-A (NZ)
Title: Calcium carbonate for plant protection
Inventor: STÜRM CHRISTOPH
IPC: A01N59/06
Filed: 2015-12-15
Abstract: The present invention relates to the use of calcium carbonate as plant protection product for topical, pre-harvest application, wherein the plant protection product controls a Botrytis and/or Drosophila suzukii during plant growth, and the calcium carbonate is in powder or aqueous suspension.